Given this dilemma, shifting focus to alternative weight loss therapies that do not rely on the leptin-melanocortin system - such as GLP-1 RAs, which have distinctly different mechanisms of action - may offer theoretical feasibility for the treatment of MC4R -deficient obesity
A provider may adjust the GLP-1 dose, recommend electrolyte supplementation, or evaluate whether the symptoms reflect an unrelated condition
Most GLP-1 medications can be stored at room temperature for product-specific durations (14 days to 6 weeks), so a single overnight period is typically acceptable if within this timeframe
Rybelsus may cause hair loss, but it is reported rarely
External reference: FDA Tirzepatide (Mounjaro) Prescribing Information How Tirzepatide Premixed Pen (30 mg) Works Tirzepatides dual-action mechanism makes it unique in the field of metabolic therapy: Appetite Suppression Reduces hunger signals to the brain, supporting reduced caloric intake
There are an awful lot of patients who do have the tenderness in those localized areas